Actively Recruiting
Epidemiology and Biomarker Study in Alzheimer's Disease
Led by Eli Lilly and Company · Updated on 2026-05-14
3400
Participants Needed
4
Research Sites
409 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Study AACU determines rates of cognitive worsening in participants within elevated and not elevated plasma P-tau217 cohorts. Participation in AACU will last approximately 7 years.
CONDITIONS
Official Title
Epidemiology and Biomarker Study in Alzheimer's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- The participant must self-report unimpaired cognition.
- The participant must have adequate literacy, vision, and hearing for neuropsychological assessments at the time of screening.
You will not qualify if you...
- Have seen a doctor about memory concerns.
- Have a history or diagnosis of cognitive impairment, or significant other neurodegenerative disease that can affect cognition.
- Are currently enrolled or have previously participated in any Alzheimer's Disease (AD)-related study involving an investigational drug intervention.
- Are currently using or have previously used prescription medications for treatment of mild cognitive impairment (MCI) or dementia such as amyloid targeting therapy (that is, lecanemab, donanemab, aducanumab), cholinesterase inhibitors (for example, benzgalantamine, donepezil, galantamine, rivastigmine), and memantine.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Care Access - Houston
Houston, Texas, United States, 77054
Actively Recruiting
2
The University of Tokyo Hospital
Bunkyō City, Japan, 113-8654
Actively Recruiting
3
Souseikai Sumida Hospital
Tokyo, Japan, 130-0004
Actively Recruiting
4
Higashi Shinjuku Clinic
Tokyo, Japan, 169-0072
Not Yet Recruiting
Research Team
T
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
CONTACT
P
Physicians interested in becoming principal investigators please contact
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here